P1 ‐062: High efficacy of HCV therapy following universal DAA access in Australia: the REACH‐C cohort
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 54-54, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐044: Low serum HBsAg and HBV DNA levels identify strongest responders of pegylated interferon addition to entecavir in HBeAg positive chronic hepatitis B
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 27-28, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐119: Evaluation of hepatitis C screening strategies in different community settings in a Canadian metropolitan area
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 166-167, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐019: The role of USP18 in macrophage polarization and interferon resistance in the liver inflammatory microenvironment
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 119-120, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐106: Very high efficacy and safety of daas in pwid with chronic hepatitis c on opiate substitution treatment with buprenorphine: real life data from central Greece
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 78-78, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐004: Safety, pharmacokinetics and antiviral activity of novel capsid assembly modulator (CAM) JNJ‐56136379 (JNJ‐6379) in treatment‐naïve chronic hepatitis B (CHB) patients without cirrhosis
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 36-36, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐005: Hepatitis E – profile and predictors of mortality: Indian experience
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 7-8, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

LBP ‐016: Lost to follow‐up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 203-203, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐146: Viral hepatitis B and C among manual sugar cane cutters in Brazil: a community‐based study
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 100-100, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐068: Hepatitis C treatment with Ledipasvir and Sofosbuvir in a low socioeconomic population at a Federally Qualified Health Center [FQHC]
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 57-58, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐050: Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 31-32, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐126: Changes in characteristics of HCV infected patients treated in Poland between 2015 and 2017 – EpiTer‐2 study
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 170-171, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐027: Enhanced virome analysis in acute liver failure patients with unknown etiology
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 122-122, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐114: Seroconversion of Hepatitis C during dialysis in Major cities of Pakistan
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 82-82, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐076: Performance evaluation of VIKIA® ANTI‐HCV, rapid test for the qualitative detection of antibodies anti‐HCV in European and non‐European populations
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 145-146, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research